- Home
- CANF vs ARBEW Comparison
CANF vs ARBEW Comparison
Compare CANF & ARBEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | ARBEW |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | Israel | Israel |
| Employees | 5 | 144 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | N/A |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CANF | ARBEW |
|---|---|---|
| Price | $3.63 | $0.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9,750.00 | N/A |
| AVG Volume (30 Days) | ★ 634.9K | 8.0K |
| Earning Date | 01-01-0001 | 03-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $768,000.00 |
| Revenue This Year | $461.72 | N/A |
| Revenue Next Year | $290,391.28 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $0.06 |
| 52 Week High | $10.40 | $0.50 |
Technical Indicators
Market Signals| Indicator | CANF | ARBEW |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 37.35 |
| Support Level | $0.60 | N/A |
| Resistance Level | $4.74 | $0.27 |
| Average True Range (ATR) | 0.71 | 0.01 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 1.16 | 7.07 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.